Target intelligence / Profile preview

Golgi pH regulator B (GPR89B)

Target
GPR89B
Molecular classification
G protein-coupled receptor, voltage-gated anion channel, transporter, receptor
01

Overview

Golgi pH regulator B (GPR89B) is a membrane protein encoded by the GPR89B gene on chromosome 1 that functions primarily as a voltage-gated anion channel within the Golgi apparatus, transferring ions such as iodide, chloride, bromide, and fluoride to support Golgi acidification and intracellular pH regulation[4][1][3]. It is also known by a range of aliases, partly reflecting its unexplored or orphan receptor status in the GPCR family, though its main activity is now considered anion transport rather than traditional GPCR ligand signaling[3][4][6]. GPR89B plays a role in lymphocyte development and is implicated in rare immunodeficiency syndromes, chromosomal disorders, and a growing set of cancers, especially as part of the broader GPCR family that is increasingly investigated for tumor targeting and personalized medicine applications[1][2][3][4][8]. No drugs are currently approved that specifically target GPR89B, but its molecular features suggest potential tractability for small molecules or antibody drug conjugates, though more functional and phenotypic clarity is needed before clinical application[8].

Other names
G protein-coupled receptor 89BGPHRGPR89GPR89CLINC02804SH120UNQ192Golgi pH regulator BGolgi pH regulator AGolgi pH regulator CHSPC201Protein GPR89Bputative MAPK-activating protein PM01putative NF-kappa-B-activating protein 90
02

Mechanism of action

Not specifically described for GPR89B as a drug target - As a family: small molecule/peptide ligand binding to modulate anion channel or signal transduction (by analogy to other GPCRs and anion channels)

03

Biological functions

Regulation of Golgi pH/intracellular pHAnion transport (voltage-gated anion channel activity for iodide, chloride, bromide, fluoride)Golgi acidificationSignal transduction (historically annotated)Lymphocyte development
04

Disease associations

Immunodeficiency (immunodeficiency 18, 19, combined immunodeficiency with skin granulomas)Chromosome 1q21.1 deletion/duplication syndromeBreast cancerPeptic ulcer diseaseOvarian cancer (implicated via GPCR family overexpression pattern)22q11.2 deletion syndrome
05

Safety considerations

No specific GPR89B-targeted safety data foundPotential safety concerns could include off-target effects related to general GPCR or anion channel modulation: altered immune function, altered Golgi or cellular pH, effects on lymphocyte development, or broader signal transduction disturbances

Beyond the preview

Go deeper on Golgi pH regulator B (GPR89B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golgi pH regulator B (GPR89B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call